J. Eble, G. Sauter, J. Epstein, I. Sesterhenn, and . Editor, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs, pp.12-1723, 2004.

J. Srigley, B. Delahunt, and J. Eble, The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia, The American Journal of Surgical Pathology, vol.37, issue.10, pp.1469-89, 2013.
DOI : 10.1097/PAS.0b013e318299f2d1

M. Sun, S. Shariat, and C. Cheng, Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review, European Urology, vol.60, issue.4, pp.644-61, 2011.
DOI : 10.1016/j.eururo.2011.06.041

T. Klatte, P. Rao, and M. De-martino, Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma, Journal of Clinical Oncology, vol.27, issue.5, pp.746-53, 2009.
DOI : 10.1200/JCO.2007.15.8345

T. Klatte, N. Kroeger, and E. Rampersaud, Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma, Cancer, vol.67, issue.suppl 2, pp.5777-82, 2012.
DOI : 10.1002/cncr.27607

J. Dagher, F. Dugay, and G. Verhoest, Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas, Human Pathology, vol.44, issue.10, pp.2106-2121, 2013.
DOI : 10.1016/j.humpath.2013.03.018

URL : https://hal.archives-ouvertes.fr/hal-00937633

A. Young, R. Craven, and D. Cohen, Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma, Clinical Cancer Research, vol.15, issue.24, pp.7582-7592, 2009.
DOI : 10.1158/1078-0432.CCR-09-2131

K. Gupta, J. Miller, J. Li, M. Russell, and C. Charbonneau, Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review, Cancer Treatment Reviews, vol.34, issue.3, pp.193-205, 2008.
DOI : 10.1016/j.ctrv.2007.12.001

C. Coppin, F. Porzsolt, A. Awa, J. Kumpf, A. Coldman et al., Immunotherapy for advanced renal cell cancer, Cochrane Database Syst Rev, issue.1, p.1425, 2005.

R. Fisher, M. Gore, and J. Larkin, Current and future systemic treatments for renal cell carcinoma, Seminars in Cancer Biology, vol.23, issue.1
DOI : 10.1016/j.semcancer.2012.06.004

G. Hudes, M. Carducci, and P. Tomczak, Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.22, pp.2271-81, 2007.
DOI : 10.1056/NEJMoa066838

F. Dugay, X. Goff, and N. Rioux-leclerq, Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosis, International Journal of Cancer, vol.135, issue.9, 2013.
DOI : 10.1002/ijc.28548

URL : https://hal.archives-ouvertes.fr/hal-01010658

A. Suzuki and S. Ohno, The PAR-aPKC system: lessons in polarity, Journal of Cell Science, vol.119, issue.6, pp.979-87, 2006.
DOI : 10.1242/jcs.02898

N. Sawada, M. Murata, and K. Kikuchi, Tight junctions and human diseases, Medical Electron Microscopy, vol.36, issue.3, pp.147-56, 2003.
DOI : 10.1007/s00795-003-0219-y

V. Aranda, M. Nolan, and S. Muthuswamy, Par complex in cancer: a regulator of normal cell polarity joins the dark side, Oncogene, vol.74, issue.55, pp.6878-87, 2008.
DOI : 10.1158/0008-5472.CAN-05-4527

L. Mccaffrey, J. Montalbano, C. Mihai, and I. Macara, Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis, Cancer Cell, vol.22, issue.5, pp.601-615, 2012.
DOI : 10.1016/j.ccr.2012.10.003

B. Xue, K. Krishnamurthy, D. Allred, and S. Muthuswamy, Loss of Par3 promotes breast cancer metastasis by compromising cell???cell cohesion, Nature Cell Biology, vol.11, issue.2, pp.189-200, 2013.
DOI : 10.1046/j.1365-2559.2002.14691.x

Y. Jan, B. Ko, and T. Liu, Expression of Partitioning Defective 3 (Par-3) for Predicting Extrahepatic Metastasis and Survival with Hepatocellular Carcinoma, International Journal of Molecular Sciences, vol.14, issue.1, pp.1684-97, 2013.
DOI : 10.3390/ijms14011684

S. Iden, W. Van-riel, and R. Schäfer, Tumor Type-Dependent Function of the Par3 Polarity Protein in Skin Tumorigenesis, Cancer Cell, vol.22, issue.3, pp.389-403, 2012.
DOI : 10.1016/j.ccr.2012.08.004

S. Edge and C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.1471-1475, 2010.
DOI : 10.1245/s10434-010-0985-4

M. Oken, R. Creech, and D. Tormey, Toxicity and response criteria of the Eastern Cooperative Oncology Group, AMERICAN JOURNAL OF CLINICAL ONCOLOGY, vol.5, issue.6, pp.649-55, 1982.
DOI : 10.1097/00000421-198212000-00014

C. Ma, S. Bandukwala, and D. Burman, Interconversion of three measures of performance status: An empirical analysis, European Journal of Cancer, vol.46, issue.18, pp.3175-83, 2010.
DOI : 10.1016/j.ejca.2010.06.126

J. Patard, E. Leray, and L. Cindolo, MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA, The Journal of Urology, vol.172, issue.3, pp.858-62, 2004.
DOI : 10.1097/01.ju.0000135837.64840.55

M. Belaud-rotureau, M. Parrens, P. Dubus, J. Garroste, A. De-mascarel et al., A Comparative Analysis of FISH, RT-PCR, PCR, and Immunohistochemistry for the Diagnosis of Mantle Cell Lymphomas, Modern Pathology, vol.15, issue.5, pp.517-542, 2002.
DOI : 10.1038/modpathol.3880556

J. Patard, N. Rioux-leclercq, and D. Masson, Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma, British Journal of Cancer, vol.94, issue.8, pp.1417-1441, 2009.
DOI : 10.1186/1471-2407-5-57

URL : https://hal.archives-ouvertes.fr/inserm-00418630

S. Rothenberg, G. Mohapatra, and M. Rivera, A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers, Cancer Research, vol.70, issue.6, pp.2158-64, 2010.
DOI : 10.1158/0008-5472.CAN-09-3458

H. Zitzelsberger, L. Hieber, and H. Richter, Gene amplification of atypical PKC-bindingPARD3 in radiation-transformed neoplastic retinal pigment epithelial cell lines, Genes, Chromosomes and Cancer, vol.96, issue.1, pp.55-64, 2004.
DOI : 10.1002/gcc.20024

V. Reuter, Renal tumors exhibiting granular cytoplasm, Semin Diagn Pathol, vol.16, issue.2, pp.135-180, 1999.

J. Thiery, H. Acloque, R. Huang, and M. Nieto, Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-90, 2009.
DOI : 10.1016/j.cell.2009.11.007